This webinar will discuss conditions under which certain compounded human drug products are exempted from compliance with cGMPs, labeling, market approval and reporting requirements. It will cover conditions that require an outsourcing facility to comply and the latest developments in drug pharmacy compounding.
Course Objective:
Do you know of sections 503A and 503B of the Federal Food, Drug and Cosmetic Act (FDCA) as it relates to drug compounding?
Section 503A provides conditions under which certain compounded human drug products are exempted from requirements such as compliance with current good manufacturing practices (CGMPs), labeling with adequate directions for use and FDA market approval. New section 503B of the FDCA enables a compounder to register with FDA to become an “outsourcing facility.” Outsourcing facilities are exempt from the above label compliance and FDA market approval requirements but are still subject to CGMP compliance, risk based FDA inspections and certain reporting requirements such as adverse event reporting.
This training seeks to inform hospital or stand-alone pharmacies, pharmacy state boards, pharmacists, health care professionals, hospitals on the various FDA documents including the latest developments concerning this topic.
Course Outline:
• Sections 503A and 503B,
• FDCA & various FDA documentation concerning this topic
• Outsourcing facility registration and reporting
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Hospitals or stand-alone pharmacies
• Pharmacy state boards
• Pharmacists
• Health care professionals
• Compliance officers
• Documentation specialists
Understanding the FDA Compounding Pharmacies Guidance
Get Instant Access 60 Minutes View Program |
FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process
Get Instant Access 90 Minutes View Program |
Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance
Get Instant Access 90 Minutes View Program |
Understanding The Regulation of Prescription Drugs
Get Instant Access 90 Minutes View Program |
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry